An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC

NCT06839989 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Mpox (Monkeypox)

Interventions

BIOLOGICAL: Mpox vaccination with MVA-BN

Sponsor

Institute of Tropical Medicine, Belgium

Collaborators

[object Object]
[object Object]